The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted Alpha-particle Therapy Market Research Report 2025
Synopsis
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Targeted Alpha-particle Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted Alpha-particle Therapy in Immunotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted Alpha-particle Therapy include Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Alpha-particle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Alpha-particle Therapy.
The Targeted Alpha-particle Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Alpha-particle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Alpha-particle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
Fusion Pharmaceuticals(AstraZeneca)
AlphaGen Therapeutics
Segment by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Segment by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Alpha-particle Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The global Targeted Alpha-particle Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted Alpha-particle Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted Alpha-particle Therapy in Immunotherapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted Alpha-particle Therapy include Bayer, Orano Med, Oncoinvent AS, Perspective Therapeutics, Ablaze Pharma, ARTBIO, Fusion Pharmaceuticals(AstraZeneca), AlphaGen Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted Alpha-particle Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Alpha-particle Therapy.
The Targeted Alpha-particle Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Alpha-particle Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Alpha-particle Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
Fusion Pharmaceuticals(AstraZeneca)
AlphaGen Therapeutics
Segment by Type
Actinium-225
Astatine-211
Lead-212
Bismuth-213
Others
Segment by Application
Immunotherapy
Peritoneal Carcinomas
Bone Metastases
Leukaemia
Melanomas
Solid Tumours
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Alpha-particle Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Actinium-225
1.2.3 Astatine-211
1.2.4 Lead-212
1.2.5 Bismuth-213
1.2.6 Others
1.3 Market by Application
1.3.1 Global Targeted Alpha-particle Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunotherapy
1.3.3 Peritoneal Carcinomas
1.3.4 Bone Metastases
1.3.5 Leukaemia
1.3.6 Melanomas
1.3.7 Solid Tumours
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Alpha-particle Therapy Market Perspective (2019-2030)
2.2 Global Targeted Alpha-particle Therapy Growth Trends by Region
2.2.1 Global Targeted Alpha-particle Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Alpha-particle Therapy Historic Market Size by Region (2019-2024)
2.2.3 Targeted Alpha-particle Therapy Forecasted Market Size by Region (2025-2030)
2.3 Targeted Alpha-particle Therapy Market Dynamics
2.3.1 Targeted Alpha-particle Therapy Industry Trends
2.3.2 Targeted Alpha-particle Therapy Market Drivers
2.3.3 Targeted Alpha-particle Therapy Market Challenges
2.3.4 Targeted Alpha-particle Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Alpha-particle Therapy Players by Revenue
3.1.1 Global Top Targeted Alpha-particle Therapy Players by Revenue (2019-2024)
3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Alpha-particle Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Alpha-particle Therapy Revenue
3.4 Global Targeted Alpha-particle Therapy Market Concentration Ratio
3.4.1 Global Targeted Alpha-particle Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Alpha-particle Therapy Revenue in 2023
3.5 Global Key Players of Targeted Alpha-particle Therapy Head office and Area Served
3.6 Global Key Players of Targeted Alpha-particle Therapy, Product and Application
3.7 Global Key Players of Targeted Alpha-particle Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Alpha-particle Therapy Breakdown Data by Type
4.1 Global Targeted Alpha-particle Therapy Historic Market Size by Type (2019-2024)
4.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (2025-2030)
5 Targeted Alpha-particle Therapy Breakdown Data by Application
5.1 Global Targeted Alpha-particle Therapy Historic Market Size by Application (2019-2024)
5.2 Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Alpha-particle Therapy Market Size (2019-2030)
6.2 North America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
6.4 North America Targeted Alpha-particle Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Alpha-particle Therapy Market Size (2019-2030)
7.2 Europe Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
7.4 Europe Targeted Alpha-particle Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Alpha-particle Therapy Market Size (2019-2030)
8.2 Asia-Pacific Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Alpha-particle Therapy Market Size (2019-2030)
9.2 Latin America Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
9.4 Latin America Targeted Alpha-particle Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Alpha-particle Therapy Market Size (2019-2030)
10.2 Middle East & Africa Targeted Alpha-particle Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Targeted Alpha-particle Therapy Introduction
11.1.4 Bayer Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Orano Med
11.2.1 Orano Med Company Details
11.2.2 Orano Med Business Overview
11.2.3 Orano Med Targeted Alpha-particle Therapy Introduction
11.2.4 Orano Med Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.2.5 Orano Med Recent Development
11.3 Oncoinvent AS
11.3.1 Oncoinvent AS Company Details
11.3.2 Oncoinvent AS Business Overview
11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Introduction
11.3.4 Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.3.5 Oncoinvent AS Recent Development
11.4 Perspective Therapeutics
11.4.1 Perspective Therapeutics Company Details
11.4.2 Perspective Therapeutics Business Overview
11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Introduction
11.4.4 Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.4.5 Perspective Therapeutics Recent Development
11.5 Ablaze Pharma
11.5.1 Ablaze Pharma Company Details
11.5.2 Ablaze Pharma Business Overview
11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Introduction
11.5.4 Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.5.5 Ablaze Pharma Recent Development
11.6 ARTBIO
11.6.1 ARTBIO Company Details
11.6.2 ARTBIO Business Overview
11.6.3 ARTBIO Targeted Alpha-particle Therapy Introduction
11.6.4 ARTBIO Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.6.5 ARTBIO Recent Development
11.7 Fusion Pharmaceuticals(AstraZeneca)
11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Details
11.7.2 Fusion Pharmaceuticals(AstraZeneca) Business Overview
11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Introduction
11.7.4 Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.7.5 Fusion Pharmaceuticals(AstraZeneca) Recent Development
11.8 AlphaGen Therapeutics
11.8.1 AlphaGen Therapeutics Company Details
11.8.2 AlphaGen Therapeutics Business Overview
11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Introduction
11.8.4 AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024)
11.8.5 AlphaGen Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Targeted Alpha-particle Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Actinium-225
Table 3. Key Players of Astatine-211
Table 4. Key Players of Lead-212
Table 5. Key Players of Bismuth-213
Table 6. Key Players of Others
Table 7. Global Targeted Alpha-particle Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Targeted Alpha-particle Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Targeted Alpha-particle Therapy Market Share by Region (2019-2024)
Table 11. Global Targeted Alpha-particle Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Targeted Alpha-particle Therapy Market Share by Region (2025-2030)
Table 13. Targeted Alpha-particle Therapy Market Trends
Table 14. Targeted Alpha-particle Therapy Market Drivers
Table 15. Targeted Alpha-particle Therapy Market Challenges
Table 16. Targeted Alpha-particle Therapy Market Restraints
Table 17. Global Targeted Alpha-particle Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Targeted Alpha-particle Therapy Market Share by Players (2019-2024)
Table 19. Global Top Targeted Alpha-particle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Alpha-particle Therapy as of 2023)
Table 20. Ranking of Global Top Targeted Alpha-particle Therapy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Targeted Alpha-particle Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Targeted Alpha-particle Therapy, Headquarters and Area Served
Table 23. Global Key Players of Targeted Alpha-particle Therapy, Product and Application
Table 24. Global Key Players of Targeted Alpha-particle Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2019-2024)
Table 28. Global Targeted Alpha-particle Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Targeted Alpha-particle Therapy Revenue Market Share by Type (2025-2030)
Table 30. Global Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2019-2024)
Table 32. Global Targeted Alpha-particle Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Targeted Alpha-particle Therapy Revenue Market Share by Application (2025-2030)
Table 34. North America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Targeted Alpha-particle Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Bayer Company Details
Table 50. Bayer Business Overview
Table 51. Bayer Targeted Alpha-particle Therapy Product
Table 52. Bayer Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 53. Bayer Recent Development
Table 54. Orano Med Company Details
Table 55. Orano Med Business Overview
Table 56. Orano Med Targeted Alpha-particle Therapy Product
Table 57. Orano Med Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 58. Orano Med Recent Development
Table 59. Oncoinvent AS Company Details
Table 60. Oncoinvent AS Business Overview
Table 61. Oncoinvent AS Targeted Alpha-particle Therapy Product
Table 62. Oncoinvent AS Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 63. Oncoinvent AS Recent Development
Table 64. Perspective Therapeutics Company Details
Table 65. Perspective Therapeutics Business Overview
Table 66. Perspective Therapeutics Targeted Alpha-particle Therapy Product
Table 67. Perspective Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 68. Perspective Therapeutics Recent Development
Table 69. Ablaze Pharma Company Details
Table 70. Ablaze Pharma Business Overview
Table 71. Ablaze Pharma Targeted Alpha-particle Therapy Product
Table 72. Ablaze Pharma Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 73. Ablaze Pharma Recent Development
Table 74. ARTBIO Company Details
Table 75. ARTBIO Business Overview
Table 76. ARTBIO Targeted Alpha-particle Therapy Product
Table 77. ARTBIO Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 78. ARTBIO Recent Development
Table 79. Fusion Pharmaceuticals(AstraZeneca) Company Details
Table 80. Fusion Pharmaceuticals(AstraZeneca) Business Overview
Table 81. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product
Table 82. Fusion Pharmaceuticals(AstraZeneca) Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 83. Fusion Pharmaceuticals(AstraZeneca) Recent Development
Table 84. AlphaGen Therapeutics Company Details
Table 85. AlphaGen Therapeutics Business Overview
Table 86. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product
Table 87. AlphaGen Therapeutics Revenue in Targeted Alpha-particle Therapy Business (2019-2024) & (US$ Million)
Table 88. AlphaGen Therapeutics Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. Targeted Alpha-particle Therapy Picture
Figure 2. Global Targeted Alpha-particle Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Targeted Alpha-particle Therapy Market Share by Type: 2023 VS 2030
Figure 4. Actinium-225 Features
Figure 5. Astatine-211 Features
Figure 6. Lead-212 Features
Figure 7. Bismuth-213 Features
Figure 8. Others Features
Figure 9. Global Targeted Alpha-particle Therapy Market Size by Application (2024-2030) & (US$ Million)
Figure 10. Global Targeted Alpha-particle Therapy Market Share by Application: 2023 VS 2030
Figure 11. Immunotherapy Case Studies
Figure 12. Peritoneal Carcinomas Case Studies
Figure 13. Bone Metastases Case Studies
Figure 14. Leukaemia Case Studies
Figure 15. Melanomas Case Studies
Figure 16. Solid Tumours Case Studies
Figure 17. Targeted Alpha-particle Therapy Report Years Considered
Figure 18. Global Targeted Alpha-particle Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Targeted Alpha-particle Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Targeted Alpha-particle Therapy Market Share by Region: 2023 VS 2030
Figure 21. Global Targeted Alpha-particle Therapy Market Share by Players in 2023
Figure 22. Global Top Targeted Alpha-particle Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Alpha-particle Therapy as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Targeted Alpha-particle Therapy Revenue in 2023
Figure 24. North America Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Targeted Alpha-particle Therapy Market Share by Country (2019-2030)
Figure 26. United States Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Targeted Alpha-particle Therapy Market Share by Country (2019-2030)
Figure 30. Germany Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Targeted Alpha-particle Therapy Market Share by Region (2019-2030)
Figure 38. China Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Targeted Alpha-particle Therapy Market Share by Country (2019-2030)
Figure 46. Mexico Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Targeted Alpha-particle Therapy Market Share by Country (2019-2030)
Figure 50. Turkey Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. UAE Targeted Alpha-particle Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Bayer Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 54. Orano Med Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 55. Oncoinvent AS Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 56. Perspective Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 57. Ablaze Pharma Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 58. ARTBIO Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 59. Fusion Pharmaceuticals(AstraZeneca) Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 60. AlphaGen Therapeutics Revenue Growth Rate in Targeted Alpha-particle Therapy Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
